Eythrocyte-anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD-1/PD-L1: preclinical characterization and results of a phase I trial
Single-dose erythrocyte–uricase conjugate with immunosuppressants induces durable immune tolerance to overcome uricase immunogenicity and treat gout
Single coadministration of erythrocyte-uricase conjugate and immunosuppressant induces durable immune tolerance for gout therapy
DNA remnants in red blood cells enable early detection of cancer
BRAF inhibitors enhance erythropoiesis and treat anemia through paradoxical activation of MAPK signaling
Lenalidomide-induced pure red cell aplasia is associated with elevated expression of MHC-I molecules on erythrocytes
MED26-enriched condensates drive erythropoiesis through modulating transcription pausing
Developing an erythrocyte‒MHC-I conjugate for cancer treatment
Evolving insights into erythrocytes in synucleinopathies
© COPYRIGHT 2023. BIAN LAB AT WESTLAKE UNIVERSITY 浙ICP备18025489号